A program to help develop new treatments for heart, lung, and blood diseases.
Coordinating Center for the NHLBI Catalyze Program
This program is helping scientists turn their exciting new ideas for treating heart, lung, blood, and sleep problems into real medicines that can help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-10209507 on NIH RePORTER |
What this research studies
This program aims to bridge the gap between laboratory research and clinical application, often referred to as the 'Valley of Death.' It provides funding, technical support, and skills development to researchers working on novel therapies for heart, lung, blood, and sleep disorders. By offering guidance from the initial discovery phase through to Investigational New Drug (IND) studies, the program seeks to accelerate the development of important medical treatments. Patients may benefit from new therapies that emerge from this translational research effort.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with heart, lung, or blood disorders who may be eligible for new therapies developed through this program.
Not a fit: Patients with conditions unrelated to heart, lung, or blood diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative treatments for serious heart, lung, and blood conditions.
How similar studies have performed: Previous programs aimed at bridging the translational gap have shown success in advancing therapies, indicating that this approach has potential for impactful outcomes.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
Researchers
- Principal investigator: Severynse-Stevens, Diana M — Research Triangle Institute
- Study coordinator: Severynse-Stevens, Diana M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.